Vident Advisory’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,515
Closed -$196K 1726
2025
Q3
$196K Sell
10,515
-1,977
-16% -$36.9K ﹤0.01% 1563
2025
Q2
$230K Sell
12,492
-810
-6% -$14.4K ﹤0.01% 1438
2025
Q1
$232K Sell
13,302
-7,583
-36% -$128K ﹤0.01% 1374
2024
Q4
$362K Sell
20,885
-14,712
-41% -$269K 0.01% 1092
2024
Q3
$662K Buy
35,597
+8,370
+31% +$141K 0.02% 797
2024
Q2
$419K Sell
27,227
-504
-2% -$7.2K 0.01% 985
2024
Q1
$410K Buy
27,731
+10,196
+58% +$141K 0.01% 901
2023
Q4
$250K Sell
17,535
-171
-1% -$2.43K 0.01% 1100
2023
Q3
$247K Buy
+17,706
New +$227K 0.01% 1016

Other funds holding SBRA

Vident Advisory's SBRA Position: Q4 2025 in Review

Vident Advisory sold out of Sabra Healthcare REIT (SBRA) in Q4 2025, closing a stake of 10,515 shares — an estimated $196K sold.

Vident Advisory first reported a position in SBRA in Q3 2023 and held it in 9 quarters. The position peaked at $662K in Q3 2024. 439 funds tracked by Wall St. Rank hold SBRA as of Q4 2025.

  • Vident Advisory reported no remaining Sabra Healthcare REIT position as of Q4 2025 after selling out during the quarter.
  • Vident Advisory sold 10,515 Sabra Healthcare REIT shares in Q4 2025, an estimated $196K.
  • Vident Advisory first reported a position in Sabra Healthcare REIT in Q3 2023 and held it in 9 quarters.
  • Vident Advisory's Sabra Healthcare REIT position peaked at $662K in Q3 2024.
  • 439 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2025.

Based on Vident Advisory's 13F filing for Q4 2025, filed 18 Feb 2026.